Temozolomide
NDC 73043-013, Temozolomide, capsule, from Devatis, Inc..
- Product NDC
- 73043-013
- Status
- Listed
- Labeler
- Devatis, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207658
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73043-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TEMOZOLOMIDE100 mg/1
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73043-013-05 | 73043001305 | 5 CAPSULE in 1 BOTTLE (73043-013-05) |
| 73043-013-14 | 73043001314 | 14 CAPSULE in 1 BOTTLE (73043-013-14) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6b263fe0-5f06-4889-bf14-4aa185470810NADAC price for package 73043001305
GET /v1/drugs/nadac/73043001305NADAC price for package 73043001314
GET /v1/drugs/nadac/73043001314
Use it
Look up 73043-013 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73043-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73043-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.